Inflammatory Skin Diseases: Advances in Biologic Therapy and Precision Dermatology

9th World Congress on Dermatology & Cosmetology

June 15-16, 2026 | Paris, France

Gregor Jemec

University of Copenhagen, Denmark

Scientific Tracks Abstracts: J Dermatol Dis

Abstract :

Chronic inflammatory skin diseases such as hidradenitis suppurativa, psoriasis, and atopic dermatitis significantly affect patient quality of life and require long-term management. This presentation reviews recent discoveries in immune dysregulation, inflammatory signaling pathways, and genetic susceptibility that have transformed modern dermatological treatment.

The session discusses advances in biologic therapies, Biography Janus kinase inhibitors, targeted immunomodulators, and personalized treatment algorithms based on molecular biomarkers. Emerging digital monitoring technologies and patient-reported outcome measures are improving disease management and therapeutic decision-making. Future research focuses on precision dermatology, biomarker guided therapy, and individualized management of chronic inflammatory skin disorders.

Biography :

Gregor Jemec is Professor of Dermatology at the University of Copenhagen, Denmark. His research focuses on inflammatory skin diseases, hidradenitis suppurativa, psoriasis, wound healing, and clinical dermatology. He is inter nationally recognized for advancing biologic therapies and translational dermatology research.